Gene-spliced tumour cells immunise mice against cancer

Brown, Phyllida
November 1991
New Scientist;11/9/91, Vol. 132 Issue 1794, p22
Presents research findings at the Johns Hopkins University in Baltimore, Maryland, that a vaccine based on genetically engineered tumor cells can seek out and destroy small cancers in mice. Description of the experiment headed by Drew Pardoll at Johns Hopkins; Belief of the researchers that interleukin-4 works by helping to present proteins from the tumor to the immune system in a more effective way.


Related Articles

  • IL-5—Induced Eosinophils Suppress the Growth of Leishmania amazonensis In Vivo and Kill Promastigotes In Vitro in Response to Either IL-4 or IFN-γ. Watanabe, Yoshiya; Hamaguchi-Tsuru, Emi; Morimoto, Norihito; Nishio, Youhei; Yagyu, Ken-ichi; Konishi, Yuko; Tominaga, Mari; Miyazaki, Jun-Ichi; Furuya, Masato; Tominaga, Akira // DNA & Cell Biology;Jul2004, Vol. 23 Issue 7, p412 

    In IL-5 transgenic mice (C3H/HeN-TgN(IL-5)-Imeg), in which 50% of peripheral blood leukocytes are eosinophils, the development of infection by Leishmania amazonensis was clearly suppressed. To determine mechanistically how this protozoan parasite is killed, we performed in vitro killing...

  • Lessons from immunology: IL4R directly promotes mammary tumor metastasis. Venmar, Katherine T; Fingleton, Barbara // OncoImmunology;Sep2014, Vol. 3 Issue 9, pN.PAG 

    Interleukin-4 (IL4), a Th2 cytokine, signals through IL4 receptors (IL4Rs) to regulate increased lymphocyte proliferation and survival. We have recently discovered that IL4 also promotes these phenotypes in mammary cancer cells expressing IL4Rs to enhance their metastatic ability. Targeting...

  • Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer. Formentini, Andrea; Braun, Philipp; Fricke, Harald; Link, Karl-Heinrich; Henne-Bruns, Doris; Kornmann, Marko // International Journal of Colorectal Disease;Oct2012, Vol. 27 Issue 10, p1369 

    Purpose: Interleukin-4 (IL-4) and interleukin-13 (IL-13) are anti-inflammatory and immunomodulatory cytokines which can influence cancer-directed immunosurveillance. Nothing is presently known about expression of these cytokines and their receptors (IL-4R and IL-13R) in colorectal cancer. The...

  • Development of Cancer Vaccine Targeting WT1 Product which is Expressed in Various Kinds of Malignant Neoplasms. Oka, Y.; Tsuboi, A.; Elisseeva, O. A.; Nakajima, H.; Oji, Y.; Sugiyama, H. // Medicinal Chemistry Reviews - Online;Dec2005, Vol. 2 Issue 6, p447 

    The Wilms' tumor gene WT1 is highly expressed not only in hematopoietic malignancies, including leukemia and myelodysplastic syndromes (MDS), but also in various kinds of solid tumors, including lung, breast, and colorectal cancer. Human cytotoxic T lymphocytes (CTLs) which could specifically...

  • Tumor Vaccine. Park, Alice // Time;11/21/2011, Vol. 178 Issue 20, p22 

    The article notes that a study tested a potential tumor vaccine that contained proteins from breast- and ovarian-cancer cells.

  • Tumor Vaccine. Park, Alice // Time International (Atlantic Edition);11/21/2011, Vol. 178 Issue 20, p20 

    The article notes that a study tested a potential tumor vaccine that contained proteins from breast- and ovarian-cancer cells.

  • Early data show vaccine may reduce tumor cells.  // Urology Times;Jul2003, Vol. 31 Issue 7, p22 

    Reports on the capability of cancer vaccine in reducing the number of tumor cells among patients with prostate cancer. Decline of tumor cells; Safety of the treatment.

  • Enhancement of GM-CSF secreting tumor cell vaccines by docetaxel through immune-dependent and independent mechanisms  // Molecular Therapy;May2004 Supplement 1, Vol. 9, p218 

    An abstract of the article "Enhancement of GM-CSF Secreting Tumor Cell Vaccines by Docetaxel through Immune- Dependent and Independent Mechanisms," by Rodney A. Prell and colleagues is presented.

  • NEW HOPE FOR A Cancer Vaccine.  // Prevention;Oct2011, Vol. 63 Issue 10, p92 

    The article reports on the efforts of researchers in formulating vaccines to fight against breast cancer, including a study cancer vaccines that would prevent the return of cancer cells by training the immune system to seek out cancer cells that have survived chemotherapy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics